Sickle Cell Disease Products - Index
Medications listed in the tables and non-FDA approved indications included in these retrospective criteria are not indicative of Texas Vendor Drug Program formulary coverage.
- Revision history
- July 26, 2024
- July 22, 2022
- April 2020 (initially developed)